Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,285 across all filing types
Latest filing 2020-06-15 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
独立董事对第四届董事会第二十二次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on a specific board meeting matter regarding guarantees for a subsidiary. It references compliance with stock exchange listing rules and company bylaws. The content is a formal opinion on a board decision, not a full report or financial statement. The document length is short (601 characters), and it does not contain financial data or detailed management discussion. This fits the category of Board/Management Information (MANG), which covers announcements of board decisions or management matters.
2020-06-15 Chinese
第四届监事会第十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the supervisory board of Tianjin Ruipu Biotechnology Co., Ltd. regarding the approval of a guarantee for a loan application by a subsidiary. It includes voting results and mentions compliance with company law and articles of association. The document is short (772 characters) and does not contain financial statements or detailed financial data. It is an announcement of a board/management decision rather than a full report or financial filing. Therefore, it fits best under Board/Management Information (MANG).
2020-06-15 Chinese
关于为控股子公司提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement by Tianjin Ruipu Biotechnology Co., Ltd. regarding the provision of a guarantee for a loan taken by its controlling subsidiary, Hubei Longxiang Pharmaceutical Technology Co., Ltd. It includes details about the guarantee amount, terms, the subsidiary's financial data, board and supervisory committee approvals, and independent directors' opinions. The document is structured as a disclosure of a corporate action related to financing support for a subsidiary, not a financial report or earnings release. It does not contain comprehensive financial statements or detailed financial analysis but rather a specific corporate announcement about a guarantee. The document length is 3651 characters, which is relatively short and typical for an announcement. It fits the description of a Capital/Financing Update (CAP) as it relates to financing activities and guarantees provided by the company for its subsidiary's loan. Therefore, the appropriate classification is CAP with high confidence.
2020-06-15 Chinese
第四届董事会第二十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Tianjin Ruipu Biotechnology Co., Ltd. It details decisions about applying for credit facilities and providing guarantees for a subsidiary. The document includes voting results and references to compliance with company law and articles of association. It does not contain financial statements or detailed financial data, nor is it a transcript or presentation. It is not an annual or interim report, nor an earnings release. The content is about board decisions and approvals, which fits the category of Board/Management Information (MANG). The document length is short (1161 characters), and it is not an announcement of a report publication but a substantive announcement of board resolutions.
2020-06-15 Chinese
第四届董事会第二十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Tianjin Ruipu Biotechnology Co., Ltd. It details decisions on adjustments to financial figures and performance targets related to prior years and stock incentive plans. The document includes voting results and mentions the inclusion of these matters in a forthcoming shareholders' meeting. It does not contain full financial statements or comprehensive financial analysis, but rather board resolutions and related disclosures. This fits the category of Board/Management Information (MANG), which covers announcements of board decisions and management matters. The document length is short (1799 characters), and it is not a report publication announcement or a certification. Therefore, the appropriate classification is MANG with high confidence.
2020-06-01 Chinese
关于调整2019年限制性股票激励计划公司层面业绩考核基数值的公告
Board/Management Information Classification · 95% confidence The document is an announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding an adjustment to the 2019 restricted stock incentive plan's company-level performance assessment base values. It details board and supervisory committee approvals and independent director opinions on the adjustment. The content focuses on changes to an equity incentive plan and related performance targets, with no financial statements or comprehensive financial data presented. The document is relatively short (1148 characters) and serves as a formal announcement of a corporate governance decision related to stock incentives rather than a full report or detailed financial disclosure. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board or senior management related to corporate governance and incentive plans.
2020-06-01 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.